Photo Immuno Nano Therapy (PINT)
Cancer (CLL, Breast Cancer, etc.)
Pre-clinicalActive
Key Facts
About Pendrea Bio
Pendrea Bio is an innovative, early-stage biotech leveraging proprietary nanoparticle platforms to create novel cancer treatments with dual mechanisms of action. Its lead asset, Ceraxa, has completed Phase 1 and shows promise in restoring chemotherapeutic efficacy and enhancing immuno-oncology agents. The company's pipeline also includes the light-activated PINT platform and a flexible RNA delivery system, positioning it at the intersection of drug delivery, immunotherapy, and gene therapy for oncology.
View full company profile